Philip R. Debruyne

机构：AZ Groeninge, Anglia Ruskin University, University of Plymouth · ORCID：0000-0001-5438-9697

发表论文 202 篇 · 总被引 3184 次 · h-index 31

代表论文

• Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study (2024 · Clinical Cancer Research · 被引 49)
• Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study (2026 · The Lancet · 被引 34)
• Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial (2025 · Nature Medicine · 被引 21)
• Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe (2025 · Quality of Life Research · 被引 10)
• Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial (2025 · Journal for ImmunoTherapy of Cancer · 被引 7)
• Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital data (2025 · ESMO Real World Data and Digital Oncology · 被引 7)